189 related articles for article (PubMed ID: 27553491)
1. Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST.
Fenerty KE; Folio LR; Patronas NJ; Marté JL; Gulley JL; Heery CR
BMC Cancer; 2016 Aug; 16(1):672. PubMed ID: 27553491
[TBL] [Abstract][Full Text] [Related]
2. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
Kabolizadeh P; Chen YL; Liebsch N; Hornicek FJ; Schwab JH; Choy E; Rosenthal DI; Niemierko A; DeLaney TF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):254-262. PubMed ID: 27986348
[TBL] [Abstract][Full Text] [Related]
3. Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?
Fenerty KE; Patronas NJ; Heery CR; Gulley JL; Folio LR
J Digit Imaging; 2016 Jun; 29(3):357-64. PubMed ID: 26596767
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.
Hayes SA; Pietanza MC; O'Driscoll D; Zheng J; Moskowitz CS; Kris MG; Ginsberg MS
Eur J Radiol; 2016 Mar; 85(3):524-33. PubMed ID: 26860663
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images.
Tan J; Liu C; Li Y; Ma Y; Xie R; Li Z; Wan H; Lui S; Wu M
Front Immunol; 2022; 13():1029656. PubMed ID: 36591295
[TBL] [Abstract][Full Text] [Related]
6. Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
Sahu S; Schernthaner R; Ardon R; Chapiro J; Zhao Y; Sohn JH; Fleckenstein F; Lin M; Geschwind JF; Duran R
Radiology; 2017 Jun; 283(3):883-894. PubMed ID: 27831830
[TBL] [Abstract][Full Text] [Related]
7. Clinical lymph node staging--influence of slice thickness and reconstruction kernel on volumetry and RECIST measurements.
Fabel M; Wulff A; Heckel F; Bornemann L; Freitag-Wolf S; Heller M; Biederer J; Bolte H
Eur J Radiol; 2012 Nov; 81(11):3124-30. PubMed ID: 22464844
[TBL] [Abstract][Full Text] [Related]
8. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
Liu K; Li G; Fan C; Zhou C; Li J
Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
[TBL] [Abstract][Full Text] [Related]
9. CT Evaluation of Lymph Nodes That Merge or Split during the Course of a Clinical Trial: Limitations of RECIST 1.1.
Shafiei A; Bagheri M; Farhadi F; Apolo AB; Biassou NM; Folio LR; Jones EC; Summers RM
Radiol Imaging Cancer; 2021 May; 3(3):e200090. PubMed ID: 33874734
[TBL] [Abstract][Full Text] [Related]
10. Response criteria in solid tumors (PERCIST/RECIST) and SUV
Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
[TBL] [Abstract][Full Text] [Related]
11. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Shady W; Kishore S; Gavane S; Do RK; Osborne JR; Ulaner GA; Gonen M; Ziv E; Boas FE; Sofocleous CT
Eur J Radiol; 2016 Jun; 85(6):1224-31. PubMed ID: 27161074
[TBL] [Abstract][Full Text] [Related]
12. Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma.
Welsh JL; Bodeker K; Fallon E; Bhatia SK; Buatti JM; Cullen JJ
Am J Surg; 2012 Nov; 204(5):580-5. PubMed ID: 22902100
[TBL] [Abstract][Full Text] [Related]
13. Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment.
Lai YC; Chang WC; Chen CB; Wang CL; Lin YF; Ho MM; Cheng CY; Huang PW; Hsu CW; Lin G
Acta Radiol; 2020 Jul; 61(7):983-991. PubMed ID: 31739675
[TBL] [Abstract][Full Text] [Related]
14. Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomography.
Knollmann FD; Kumthekar R; Fetzer D; Socinski MA
Clin Lung Cancer; 2014 Mar; 15(2):103-9. PubMed ID: 24361250
[TBL] [Abstract][Full Text] [Related]
15. Comparing RECIST with EORTC criteria in metastatic bladder cancer.
Öztürk H
J Cancer Res Clin Oncol; 2016 Jan; 142(1):187-94. PubMed ID: 26208817
[TBL] [Abstract][Full Text] [Related]
16. Automatic segmentation and RECIST score evaluation in osteosarcoma using diffusion MRI: A computer aided system process.
Baidya Kayal E; Kandasamy D; Yadav R; Bakhshi S; Sharma R; Mehndiratta A
Eur J Radiol; 2020 Dec; 133():109359. PubMed ID: 33129104
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of RECIST 1.1 and iRECIST for Response Evaluation in Solid Tumours].
Houdek Š; Büchler T; Kindlová E
Klin Onkol; 2017; 30(Supplementum3):32-39. PubMed ID: 29239190
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.
Krajewski KM; Guo M; Van den Abbeele AD; Yap J; Ramaiya N; Jagannathan J; Heng DY; Atkins MB; McDermott DF; Schutz FA; Pedrosa I; Choueiri TK
Eur Urol; 2011 May; 59(5):856-62. PubMed ID: 21306819
[TBL] [Abstract][Full Text] [Related]
19. RECIST 1.1 compared with RECIST 1.0 in patients with advanced renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
Krajewski KM; Nishino M; Ramaiya NH; Choueiri TK
AJR Am J Roentgenol; 2015 Mar; 204(3):W282-8. PubMed ID: 25714313
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
